In addition, bile acids can bind to the nuclear Farnesoid X receptor (FXR), which is involved in hepatic lipid and glucose metabolism [81] and hence promotes metabolic liver dysfunction, leading to obesity, insulin resistance (see Figure 1), and nonalcoholic fatty liver disease (NAFLD). This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.